{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:55:54Z","timestamp":1787583354487,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T00:00:00Z","timestamp":1405555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T00:00:00Z","timestamp":1405555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00702-014-1242-y","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T15:32:50Z","timestamp":1405524770000},"page":"1007-1027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Towards Neuroimmunotherapy for Cancer: the Neurotransmitters Glutamate, Dopamine and GnRH-II augment substantially the ability of T cells of few Head and Neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains"],"prefix":"10.1007","volume":"121","author":[{"given":"Sven","family":"Saussez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Laumbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Chantrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhai","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Wank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Levite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,17]]},"reference":[{"key":"1242_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92\u201398","journal-title":"J Clin Oncol"},{"key":"1242_CR2","doi-asserted-by":"publisher","first-page":"11146","DOI":"10.1158\/0008-5472.CAN-05-0772","volume":"65","author":"A Albers","year":"2005","unstructured":"Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, Ferris RL (2005) Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res 65:11146\u201311155","journal-title":"Cancer Res"},{"key":"1242_CR3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","volume":"16","author":"M Al-Sarraf","year":"1998","unstructured":"Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310\u20131317","journal-title":"J Clin Oncol"},{"key":"1242_CR4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4049\/jimmunol.151.3.1175","volume":"151","author":"TM Aune","year":"1993","unstructured":"Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA (1993) Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol 151:1175\u20131183","journal-title":"J Immunol"},{"key":"1242_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0165-5728(99)00176-9","volume":"102","author":"S Basu","year":"2000","unstructured":"Basu S, Dasgupta PS (2000) Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 102:113\u2013124","journal-title":"J Neuroimmunol"},{"key":"1242_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jneuroim.2005.07.013","volume":"169","author":"MJ Besser","year":"2005","unstructured":"Besser MJ, Ganor Y, Levite M (2005) Dopamine by itself activates either D2, D3 or D1\/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both. J Neuroimmunol 169:161\u2013171","journal-title":"J Neuroimmunol"},{"key":"1242_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/(SICI)1097-4644(19980101)68:1<62::AID-JCB6>3.0.CO;2-U","volume":"68","author":"A Cardoso","year":"1998","unstructured":"Cardoso A, el Ghamrawy C, Gautron JP, Horvat B, Gautier N, Enjalbert A, Krantic S (1998) Somatostatin increases mitogen-induced IL-2 secretion and proliferation of human Jurkat T cells via sst3 receptor isotype. J Cell Biochem 68:62\u201373","journal-title":"J Cell Biochem"},{"key":"1242_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/cmi.2010.29","volume":"7","author":"K Chakraborty","year":"2008","unstructured":"Chakraborty K, Bose A, Chakraborty T, Sarkar K, Goswami S, Pal S, Baral R (2008) Restoration of dysregulated CC chemokine signaling for monocyte\/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity. Cell Mol Immunol 7:396\u2013408","journal-title":"Cell Mol Immunol"},{"key":"1242_CR9","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/nm1202-801","volume":"8","author":"A Chen","year":"2002","unstructured":"Chen A, Ganor Y, Rahimipour S, Ben-Aroya N, Koch Y, Levite M (2002) The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat Med 8:1421\u20131426","journal-title":"Nat Med"},{"key":"1242_CR10","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.4049\/jimmunol.165.6.2955","volume":"165","author":"Y Chowers","year":"2000","unstructured":"Chowers Y, Cahalon L, Lahav M, Schor H, Tal R, Bar-Meir S, Levite M (2000) Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells. J Immunol 165:2955\u20132961","journal-title":"J Immunol"},{"key":"1242_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1182\/blood-2006-01-028423","volume":"109","author":"M Cosentino","year":"2007","unstructured":"Cosentino M, Fietta AM, Ferrari M, Rasini E, Bombelli R, Carcano E, Saporiti F, Meloni F, Marino F, Lecchini S (2007) Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine\/paracrine inhibitory functional loop. Blood 109:632\u2013642","journal-title":"Blood"},{"key":"1242_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ymthe.2005.06.481","volume":"13","author":"S Dasgupta","year":"2006","unstructured":"Dasgupta S, Bhattacharya-Chatterjee M, O\u2019Malley BW Jr, Chatterjee SK (2006) Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma. Mol Ther 13:183\u2013193","journal-title":"Mol Ther"},{"key":"1242_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","volume":"22","author":"F Denis","year":"2004","unstructured":"Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Calais G (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22:69\u201376","journal-title":"J Clin Oncol"},{"key":"1242_CR14","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1095\/biolreprod.102.012211","volume":"68","author":"VD Dixit","year":"2003","unstructured":"Dixit VD, Yang H, Udhayakumar V, Sridaran R (2003) Gonadotropin-releasing hormone alters the T helper cytokine balance in the pregnant rat. Biol Reprod 68:2215\u20132221","journal-title":"Biol Reprod"},{"key":"1242_CR15","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1200\/JCO.2012.46.6441","volume":"31","author":"ME Dudley","year":"2013","unstructured":"Dudley ME, Gross CA, Somerville RP, Hong Y, Schaub NP, Rosati SF, White DE, Nathan D, Restifo NP, Steinberg SM, Wunderlich JR, Kammula US, Sherry RM, Yang JC, Phan GQ, Hughes MS, Laurencot CM, Rosenberg SA (2013) Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma. J Clin Oncol 31:2152\u20132159","journal-title":"J Clin Oncol"},{"key":"1242_CR16","first-page":"3468","volume":"59","author":"DC Duffey","year":"1999","unstructured":"Duffey DC, Chen Z, Dong G, Ondrey FG, Wolf JS, Brown K, Siebenlist U, Van Waes C (1999) Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 59:3468\u20133474","journal-title":"Cancer Res"},{"key":"1242_CR17","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/lary.23298","volume":"122","author":"A Duray","year":"2013","unstructured":"Duray A, Descamps G, Decaestecker C, Remmelink M, Sirtaine N, Lechien J, Ernoux-Neufcoeur P, Bletard N, Somja J, Depuydt CE, Delvenne P, Saussez S (2013) Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 122:1558\u20131565","journal-title":"Laryngoscope"},{"key":"1242_CR18","doi-asserted-by":"crossref","unstructured":"Eshhar Z (2008) The T-body approach: redirecting T cells with antibody specificity. Handbook of experimental pharmacology pp 329\u2013342","DOI":"10.1007\/978-3-540-73259-4_14"},{"key":"1242_CR19","first-page":"55","volume":"12","author":"Z Eshhar","year":"2010","unstructured":"Eshhar Z (2010) Adoptive cancer immunotherapy using genetically engineered designer T-cells: first steps into the clinic. Curr Opin Mol Ther 12:55\u201363","journal-title":"Curr Opin Mol Ther"},{"key":"1242_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/clin.1997.4384","volume":"84","author":"J Eugen-Olsen","year":"1997","unstructured":"Eugen-Olsen J, Afzelius P, Andresen L, Iversen J, Kronborg G, Aabech P, Nielsen JO, Hofmann B (1997) Serotonin modulates immune function in T cells from HIV-seropositive subjects. Clin Immunol Immunopathol 84:115\u2013121","journal-title":"Clin Immunol Immunopathol"},{"key":"1242_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/ijc.2910590607","volume":"59","author":"F Farace","year":"1994","unstructured":"Farace F, Angevin E, Vanderplancke J, Escudier B, Triebel F (1994) The decreased expression of CD3zeta chains in cancer patients is not reversed by IL-2 administration. Int J Cancer 59:752\u2013755","journal-title":"Int J Cancer"},{"key":"1242_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1385\/IR:33:2:113","volume":"33","author":"RL Ferris","year":"2005","unstructured":"Ferris RL, Hunt JL, Ferrone S (2005) Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance. Immunol Res 33:113\u2013133","journal-title":"Immunol Res"},{"key":"1242_CR23","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1093\/jnci\/91.24.2065","volume":"91","author":"AA Forastiere","year":"1999","unstructured":"Forastiere AA, Trotti A (1999) Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer. J Natl Cancer Inst 91:2065\u20132066","journal-title":"J Natl Cancer Inst"},{"key":"1242_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/CJI.0b013e31825898c5","volume":"35","author":"KM Friedman","year":"2012","unstructured":"Friedman KM, Prieto PA, Devillier LE, Gross CA, Yang JC, Wunderlich JR, Rosenberg SA, Dudley ME (2012) Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes. J Immunother 35:400\u2013408","journal-title":"J Immunother"},{"key":"1242_CR25","doi-asserted-by":"crossref","unstructured":"Ganor Y, Levite M (2012) Glutamate in the immune system: glutamate receptors in immune cells, potent effects, endogenous production and involvement in disease. In: Levite M (ed) Nerve-Driven Immunity: Neurotransmitters and Neuropeptides in the immune system. Springer, Berlin pp 121\u2013161","DOI":"10.1007\/978-3-7091-0888-8_4"},{"key":"1242_CR26","doi-asserted-by":"crossref","unstructured":"Ganor Y, Levite M (2014) The Neurotransmitter Glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. J Neural Trans. (in press, Abstract available on line ahead of press)","DOI":"10.1007\/s00702-014-1167-5"},{"key":"1242_CR27","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.4049\/jimmunol.170.8.4362","volume":"170","author":"Y Ganor","year":"2003","unstructured":"Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M (2003) Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol 170:4362\u20134372","journal-title":"J Immunol"},{"key":"1242_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4049\/jimmunol.178.2.683","volume":"178","author":"Y Ganor","year":"2007","unstructured":"Ganor Y, Teichberg VI, Levite M (2007) TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine\/paracrine granzyme B-mediated proteolytic cleavage. J Immunol 178:683\u2013692","journal-title":"J Immunol"},{"key":"1242_CR29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/10428190902878448","volume":"50","author":"Y Ganor","year":"2009","unstructured":"Ganor Y, Grinberg I, Reis A, Cooper I, Goldstein RS, Levite M (2009) Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147\/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo. Leuk Lymphoma 50:985\u2013997","journal-title":"Leuk Lymphoma"},{"key":"1242_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0196-9781(99)00036-4","volume":"20","author":"CE Ghamrawy","year":"1999","unstructured":"Ghamrawy CE, Rabourdin-Combe C, Krantic S (1999) sst5 somatostatin receptor mRNA induction by mitogenic activation of human T-lymphocytes. Peptides 20:305\u2013311","journal-title":"Peptides"},{"key":"1242_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S1567-5769(03)00100-0","volume":"3","author":"MC Ghosh","year":"2003","unstructured":"Ghosh MC, Mondal AC, Basu S, Banerjee S, Majumder J, Bhattacharya D, Dasgupta PS (2003) Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. Int Immunopharmacol 3:1019\u20131026","journal-title":"Int Immunopharmacol"},{"key":"1242_CR32","doi-asserted-by":"publisher","first-page":"8126","DOI":"10.1158\/0008-5472.CAN-04-2445","volume":"64","author":"JR Grandis","year":"2004","unstructured":"Grandis JR, Pietenpol JA, Greenberger JS, Pelroy RA, Mohla S (2004) Head and neck cancer: meeting summary and research opportunities. Cancer Res 64:8126\u20138129","journal-title":"Cancer Res"},{"key":"1242_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-065X.2009.00843.x","volume":"232","author":"CS Guy","year":"2009","unstructured":"Guy CS, Vignali DA (2009) Organization of proximal signal initiation at the TCR: CD3 complex. Immunol Rev 232:7\u201321","journal-title":"Immunol Rev"},{"key":"1242_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/01.mlg.0000157850.16649.b8","volume":"115","author":"B Hathaway","year":"2005","unstructured":"Hathaway B, Landsittel DP, Gooding W, Whiteside TL, Grandis JR, Siegfried JM, Bigbee WL, Ferris RL (2005) Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients. Laryngoscope 115:522\u2013527","journal-title":"Laryngoscope"},{"key":"1242_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/(SICI)1097-0320(19980601)32:2<109::AID-CYTO6>3.0.CO;2-G","volume":"32","author":"CG Healy","year":"1998","unstructured":"Healy CG, Simons JW, Carducci MA, DeWeese TL, Bartkowski M, Tong KP, Bolton WE (1998) Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer. Cytometry 32:109\u2013119","journal-title":"Cytometry"},{"key":"1242_CR36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1089\/hum.2007.0171","volume":"19","author":"B Heemskerk","year":"2008","unstructured":"Heemskerk B, Liu K, Dudley ME, Johnson LA, Kaiser A, Downey S, Zheng Z, Shelton TE, Matsuda K, Robbins PF, Morgan RA, Rosenberg SA (2008) Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2. Hum Gene Ther 19:496\u2013510","journal-title":"Hum Gene Ther"},{"key":"1242_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12132","volume":"257","author":"CS Hinrichs","year":"2014","unstructured":"Hinrichs CS, Rosenberg SA (2014) Exploiting the curative potential of adoptive T-cell therapy for cancer. Immunol Rev 257:56\u201371","journal-title":"Immunol Rev"},{"key":"1242_CR38","first-page":"2553","volume":"8","author":"TK Hoffmann","year":"2002","unstructured":"Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL (2002) Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8:2553\u20132562","journal-title":"Clin Cancer Res"},{"key":"1242_CR39","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00262-004-0530-z","volume":"53","author":"TK Hoffmann","year":"2004","unstructured":"Hoffmann TK, Bier H, Whiteside TL (2004) Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 53:1055\u20131067","journal-title":"Cancer Immunol Immunother"},{"key":"1242_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1046\/j.1365-2567.1996.d01-653.x","volume":"88","author":"E Josefsson","year":"1996","unstructured":"Josefsson E, Bergquist J, Ekman R, Tarkowski A (1996) Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88:140\u2013146","journal-title":"Immunology"},{"key":"1242_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000026321","volume":"5","author":"N Kawamura","year":"1998","unstructured":"Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata A, Yamamoto H (1998) Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5:9\u201315","journal-title":"Neuroimmunomodulation"},{"key":"1242_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0347(199607\/08)18:4<335::AID-HED4>3.0.CO;2-Z","volume":"18","author":"JD Kerrebijn","year":"1996","unstructured":"Kerrebijn JD, Simons PJ, Balm AJ, Tas M, Knegt PP, de Vries N, Tan IB, Drexhage HA (1996) Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma. Head Neck 18:335\u2013342","journal-title":"Head Neck"},{"issue":"Pt 1","key":"1242_CR43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/0264-6021:3440199","volume":"344","author":"NA Khan","year":"1999","unstructured":"Khan NA, Hichami A (1999) Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase C-dependent phospholipase D pathway in human T-cells. Biochem J 344(Pt 1):199\u2013204","journal-title":"Biochem J"},{"key":"1242_CR44","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1523\/JNEUROSCI.0600-04.2004","volume":"24","author":"J Kipnis","year":"2004","unstructured":"Kipnis J, Cardon M, Avidan H, Lewitus GM, Mordechay S, Rolls A, Shani Y, Schwartz M (2004) Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration. J Neurosci 24:6133\u20136143","journal-title":"J Neurosci"},{"key":"1242_CR45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0031-6997(24)01510-2","volume":"53","author":"AP Kohm","year":"2001","unstructured":"Kohm AP, Sanders VM (2001) Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53:487\u2013525","journal-title":"Pharmacol Rev"},{"key":"1242_CR46","first-page":"1825","volume":"2","author":"K Kono","year":"1996","unstructured":"Kono K, Ressing ME, Brandt RM, Melief CJ, Potkul RK, Andersson B, Petersson M, Kast WM, Kiessling R (1996) Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 2:1825\u20131828","journal-title":"Clin Cancer Res"},{"key":"1242_CR47","first-page":"329","volume":"5","author":"I Kuss","year":"1999","unstructured":"Kuss I, Saito T, Johnson JT, Whiteside TL (1999) Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res 5:329\u2013334","journal-title":"Clin Cancer Res"},{"key":"1242_CR48","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3109\/08923979209009235","volume":"14","author":"JL Kut","year":"1992","unstructured":"Kut JL, Young MR, Crayton JW, Wright MA, Young ME (1992) Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin. Immunopharmacol Immunotoxicol 14:783\u2013796","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1242_CR49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4049\/jimmunol.156.1.310","volume":"156","author":"S Laberge","year":"1996","unstructured":"Laberge S, Cruikshank WW, Beer DJ, Center DM (1996) Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol 156:310\u2013315","journal-title":"J Immunol"},{"key":"1242_CR50","first-page":"161","volume":"2","author":"P Lai","year":"1996","unstructured":"Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL (1996) Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 2:161\u2013173","journal-title":"Clin Cancer Res"},{"key":"1242_CR200","doi-asserted-by":"crossref","unstructured":"Laumbacher B, Gu S, Wank R (2012) Activated monocytes prime na\u00efve T cells against autologous cancer: vigorous cancer destruction in vitro and in vivo. Scand J Immunol 75(3):314\u2013328","DOI":"10.1111\/j.1365-3083.2011.02652.x"},{"key":"1242_CR300","doi-asserted-by":"crossref","unstructured":"Laumbacher B, Gu S, Wank R (2013) Prolongation of life by adoptive cell therapy with cascade primed immune cells in four patients with non-small cell lung cancer stages IIIB and IV and a pancoast tumor: a case series. J Med Case Rep 7(1):266","DOI":"10.1186\/1752-1947-7-266"},{"key":"1242_CR51","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1182\/blood-2006-10-052787","volume":"109","author":"M Leon-Ponte","year":"2007","unstructured":"Leon-Ponte M, Ahern GP, O\u2019Connell PJ (2007) Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 109:3139\u20133146","journal-title":"Blood"},{"key":"1242_CR52","doi-asserted-by":"publisher","first-page":"12544","DOI":"10.1073\/pnas.95.21.12544","volume":"95","author":"M Levite","year":"1998","unstructured":"Levite M (1998) Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA 95:12544\u201312549","journal-title":"Proc Natl Acad Sci USA"},{"key":"1242_CR53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1749-6632.2000.tb05397.x","volume":"917","author":"M Levite","year":"2000","unstructured":"Levite M (2000) Nerve-driven immunity: the direct effects of neurotransmitters on T-cell function. Ann N Y Acad Sci 917:307\u2013321","journal-title":"Ann N Y Acad Sci"},{"key":"1242_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1471-4906(00)01799-3","volume":"22","author":"M Levite","year":"2001","unstructured":"Levite M (2001) Nervous immunity: Neurotransmitters, extracellular K+ and T-cell function. Trends Immunol 22:2\u20135","journal-title":"Trends Immunol"},{"key":"1242_CR55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.coph.2008.05.001","volume":"8","author":"M Levite","year":"2008","unstructured":"Levite M (2008) Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol 8:460\u2013471","journal-title":"Curr Opin Pharmacol"},{"key":"1242_CR56","doi-asserted-by":"crossref","unstructured":"Levite M (2012a) Dopamine in the immune system: dopamine receptors in immune cells, potent effects, endogenous production and involvement in immune and neuropsychiatric diseases. In: Levite M (ed) Nerve-driven immunity: Neurotransmitters and Neuropeptides in the immune system. Springer, Berlin, pp 1\u201345","DOI":"10.1007\/978-3-7091-0888-8_1"},{"key":"1242_CR57","doi-asserted-by":"crossref","unstructured":"Levite M (2012b) Nerve-driven immunity: Neurotransmitters and neuropeptides in the immune system. Springer, Berlin, pp 1\u2013359","DOI":"10.1007\/978-3-7091-0888-8_1"},{"key":"1242_CR58","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.160.2.993","volume":"160","author":"M Levite","year":"1998","unstructured":"Levite M, Cahalon L, Hershkoviz R, Steinman L, Lider O (1998) Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin. J Immunol 160:993\u20131000","journal-title":"J Immunol"},{"key":"1242_CR59","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1084\/jem.191.7.1167","volume":"191","author":"M Levite","year":"2000","unstructured":"Levite M, Cahalon L, Peretz A, Hershkoviz R, Sobko A, Ariel A, Desai R, Attali B, Lider O (2000) Extracellular K(+) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins. J Exp Med 191:1167\u20131176","journal-title":"J Exp Med"},{"key":"1242_CR60","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1002\/1521-4141(200112)31:12<3504::AID-IMMU3504>3.0.CO;2-F","volume":"31","author":"M Levite","year":"2001","unstructured":"Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L (2001) Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur J Immunol 31:3504\u20133512","journal-title":"Eur J Immunol"},{"key":"1242_CR61","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.4049\/jimmunol.176.6.3402","volume":"176","author":"A Lopez-Albaitero","year":"2006","unstructured":"Lopez-Albaitero A, Nayak JV, Ogino T, Machandia A, Gooding W, DeLeo AB, Ferrone S, Ferris RL (2006) Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL. J Immunol 176:3402\u20133409","journal-title":"J Immunol"},{"key":"1242_CR62","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.4049\/jimmunol.163.12.6912","volume":"163","author":"C Maccalli","year":"1999","unstructured":"Maccalli C, Pisarra P, Vegetti C, Sensi M, Parmiani G, Anichini A (1999) Differential loss of T cell signaling molecules in metastatic melanoma patient\u2019s T lymphocyte subsets expressing distinct TCR variable regions. J Immunol 163:6912\u20136923","journal-title":"J Immunol"},{"issue":"1375\u20131384","key":"1242_CR63","first-page":"e1371","volume":"143","author":"A Maliar","year":"2012","unstructured":"Maliar A, Servais C, Waks T, Chmielewski M, Lavy R, Altevogt P, Abken H, Eshhar Z (2012) Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in mice. Gastroenterology 143(1375\u20131384):e1371\u2013e1375","journal-title":"Gastroenterology"},{"key":"1242_CR64","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni0608-583","volume":"9","author":"B Malissen","year":"2008","unstructured":"Malissen B (2008) CD3 ITAMs count! Nat Immunol 9:583\u2013584","journal-title":"Nat Immunol"},{"key":"1242_CR65","doi-asserted-by":"crossref","unstructured":"Marcus A, Eshhar Z (2014) Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer. Expert Opinion Biol Ther 14(7):947\u2013954","DOI":"10.1517\/14712598.2014.900540"},{"key":"1242_CR66","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1182\/blood-2011-02-334284","volume":"118","author":"A Marcus","year":"2011","unstructured":"Marcus A, Waks T, Eshhar Z (2011) Redirected tumor-specific allogeneic T cells for universal treatment of cancer. Blood 118:975\u2013983","journal-title":"Blood"},{"key":"1242_CR67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","volume":"132","author":"F McKenna","year":"2002","unstructured":"McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, Moots RJ (2002) Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 132:34\u201340","journal-title":"J Neuroimmunol"},{"key":"1242_CR68","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bcp.2005.04.038","volume":"70","author":"G Miglio","year":"2005","unstructured":"Miglio G, Varsaldi F, Dianzani C, Fantozzi R, Lombardi G (2005) Stimulation of group I metabotropic glutamate receptors evokes calcium signals and c-jun and c-fos gene expression in human T cells. Biochem Pharmacol 70:189\u2013199","journal-title":"Biochem Pharmacol"},{"key":"1242_CR69","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0162-3109(90)90036-E","volume":"20","author":"TC Moore","year":"1990","unstructured":"Moore TC, Whitley GA, Lami JL, Said SI (1990) Substance P increases and prolongs increased output of T4 (CD4) lymphocytes from lymph nodes of sheep in vivo: is it a mediator of immunological memory? Immunopharmacology 20:207\u2013216","journal-title":"Immunopharmacology"},{"key":"1242_CR70","first-page":"5610","volume":"53","author":"H Nakagomi","year":"1993","unstructured":"Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin JL, Vivier E, Anderson P, Kiessling R (1993) Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 53:5610\u20135612","journal-title":"Cancer Res"},{"key":"1242_CR71","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.tibtech.2011.04.009","volume":"29","author":"TS Park","year":"2011","unstructured":"Park TS, Rosenberg SA, Morgan RA (2011) Treating cancer with genetically engineered T cells. Trends Biotechnol 29:550\u2013557","journal-title":"Trends Biotechnol"},{"key":"1242_CR72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/107327481302000406","volume":"20","author":"GQ Phan","year":"2013","unstructured":"Phan GQ, Rosenberg SA (2013) Adoptive cell transfer for patients with metastatic melanoma: the potential and promise of cancer immunotherapy. Cancer Control 20:289\u2013297","journal-title":"Cancer Control"},{"key":"1242_CR73","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S0194-5998(03)00478-9","volume":"129","author":"MJ Ramirez","year":"2003","unstructured":"Ramirez MJ, Ferriol EE, Domenech FG, Llatas MC, Suarez-Varela MM, Martinez RL (2003) Psychosocial adjustment in patients surgically treated for laryngeal cancer. Otolaryngol Head Neck Surg 129:92\u201397","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1242_CR74","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00002371-199807000-00007","volume":"21","author":"TE Reichert","year":"1998","unstructured":"Reichert TE, Rabinowich H, Johnson JT, Whiteside TL (1998) Mechanisms responsible for signaling and functional defects. J Immunother 21:295\u2013306","journal-title":"J Immunother"},{"key":"1242_CR75","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","volume":"17","author":"SA Rosenberg","year":"2011","unstructured":"Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME (2011) Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res 17:4550\u20134557","journal-title":"Clin Cancer Res"},{"key":"1242_CR76","first-page":"1263","volume":"5","author":"T Saito","year":"1999","unstructured":"Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL (1999) Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin Cancer Res 5:1263\u20131273","journal-title":"Clin Cancer Res"},{"key":"1242_CR77","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0165-5728(93)90170-4","volume":"45","author":"L Santambrogio","year":"1993","unstructured":"Santambrogio L, Lipartiti M, Bruni A, Dal Toso R (1993) Dopamine receptors on human T- and B-lymphocytes. J Neuroimmunol 45:113\u2013119","journal-title":"J Neuroimmunol"},{"key":"1242_CR78","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000068327","volume":"10","author":"G Santoni","year":"2002","unstructured":"Santoni G, Amantini C, Lucciarini R, Pompei P, Perfumi M, Nabissi M, Morrone S, Piccoli M (2002) Expression of substance P and its neurokinin-1 receptor on thymocytes: functional relevance in the regulation of thymocyte apoptosis and proliferation. Neuroimmunomodulation 10:232\u2013246","journal-title":"Neuroimmunomodulation"},{"key":"1242_CR79","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jneuroim.2007.05.021","volume":"188","author":"P Sarchielli","year":"2007","unstructured":"Sarchielli P, Di Filippo M, Candeliere A, Chiasserini D, Mattioni A, Tenaglia S, Bonucci M, Calabresi P (2007) Expression of ionotropic glutamate receptor GluR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. J Neuroimmunol 188:146\u2013158","journal-title":"J Neuroimmunol"},{"key":"1242_CR80","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.4049\/jimmunol.177.11.7525","volume":"177","author":"C Sarkar","year":"2006","unstructured":"Sarkar C, Das S, Chakroborty D, Chowdhury UR, Basu B, Dasgupta PS, Basu S (2006) Cutting edge: stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1\/ERK2 phosphorylation. J Immunol 177:7525\u20137529","journal-title":"J Immunol"},{"key":"1242_CR81","first-page":"453","volume":"165","author":"S Saussez","year":"2010","unstructured":"Saussez S (2010) Cancer of the upper aero-digestive tract: elevated incidence in Belgium, new risk factors and therapeutic perspectives. Bull Mem Acad R Med Belg 165:453\u2013461 discussion 462\u2013453","journal-title":"Bull Mem Acad R Med Belg"},{"key":"1242_CR82","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/hed.20559","volume":"29","author":"S Saussez","year":"2007","unstructured":"Saussez S, Camby I, Toubeau G, Kiss R (2007) Galectins as modulators of tumor progression in head and neck squamous cell carcinomas. Head Neck 29:874\u2013884","journal-title":"Head Neck"},{"key":"1242_CR83","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/02656730902852677","volume":"25","author":"J Schmidtner","year":"2009","unstructured":"Schmidtner J, Distel LV, Ott OJ, Nkenke E, Sprung CN, Fietkau R, Lubgan D (2009) Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes. Int J Hyperthermia 25:347\u2013354","journal-title":"Int J Hyperthermia"},{"key":"1242_CR84","first-page":"352p","volume":"232\u2013236","author":"J Shah","year":"2003","unstructured":"Shah J, Patel S (2003) Head and neck surgery and oncology. New York Mosby 232\u2013236:352p","journal-title":"New York Mosby"},{"key":"1242_CR85","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.4049\/jimmunol.174.9.5490","volume":"174","author":"GV Shurin","year":"2005","unstructured":"Shurin GV, Ferris RL, Tourkova IL, Perez L, Lokshin A, Balkir L, Collins B, Chatta GS, Shurin MR (2005) Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol 174:5490\u20135498","journal-title":"J Immunol"},{"key":"1242_CR86","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","volume":"27","author":"JE Smith-Garvin","year":"2009","unstructured":"Smith-Garvin JE, Koretzky GA, Jordan MS (2009) T cell activation. Annu Rev Immunol 27:591\u2013619","journal-title":"Annu Rev Immunol"},{"key":"1242_CR87","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1038\/jid.2009.204","volume":"129","author":"P Straten","year":"2009","unstructured":"Straten P, Becker JC (2009) Adoptive cell transfer in the treatment of metastatic melanoma. J Invest Dermatol 129:2743\u20132745","journal-title":"J Invest Dermatol"},{"key":"1242_CR88","doi-asserted-by":"crossref","unstructured":"Tanriverdi FD, Gonzalez-Martinez LF, Silveira Y, Hu GS, Maccoll P, Travers, Bouloux PM (2004) Expression of gonadotropin-releasing hormone type-I (GnRH-I) and type-II (GnRH-II) in human peripheral blood mononuclear cells (PMBCs) and regulation of B-lymphoblastoid cell proliferation by GnRH-I and GnRH-II. Exp Clin Endocrinol Diabetes 112:587\u2013594","DOI":"10.1055\/s-2004-830404"},{"key":"1242_CR89","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2249.2005.02904.x","volume":"142","author":"F Tanriverdi","year":"2005","unstructured":"Tanriverdi F, Gonzalez-Martinez D, Hu Y, Kelestimur F, Bouloux PM (2005) GnRH-I and GnRH-II have differential modulatory effects on human peripheral blood mononuclear cell proliferation and interleukin-2 receptor gamma-chain mRNA expression in healthy males. Clin Exp Immunol 142:103\u2013110","journal-title":"Clin Exp Immunol"},{"key":"1242_CR90","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0165-5728(96)00143-9","volume":"71","author":"R Vishwanath","year":"1996","unstructured":"Vishwanath R, Mukherjee R (1996) Substance P promotes lymphocyte-endothelial cell adhesion preferentially via LFA-1\/ICAM-1 interactions. J Neuroimmunol 71:163\u2013171","journal-title":"J Neuroimmunol"},{"key":"1242_CR400","doi-asserted-by":"crossref","unstructured":"Wank R, Song X, Gu S, Laumbacher B (2014) Benefits of a continuous therapy for cancer patients with a novel adoptive cell therapy by cascade priming (CAPRI). Immunotherapy 6(3):269\u2013282","DOI":"10.2217\/imt.14.6"},{"key":"1242_CR91","doi-asserted-by":"publisher","first-page":"848","DOI":"10.4049\/jimmunol.176.2.848","volume":"176","author":"Y Watanabe","year":"2006","unstructured":"Watanabe Y, Nakayama T, Nagakubo D, Hieshima K, Jin Z, Katou F, Hashimoto K, Yoshie O (2006) Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol 176:848\u2013856","journal-title":"J Immunol"},{"key":"1242_CR92","first-page":"865","volume":"53","author":"TL Whiteside","year":"2004","unstructured":"Whiteside TL (2004) Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer? Cancer Immunol Immunother 53:865\u2013878","journal-title":"Cancer Immunol Immunother"},{"key":"1242_CR93","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10555-005-5050-6","volume":"24","author":"TL Whiteside","year":"2005","unstructured":"Whiteside TL (2005) Immunobiology of head and neck cancer. Cancer Metastasis Rev 24:95\u2013105","journal-title":"Cancer Metastasis Rev"},{"key":"1242_CR94","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jneuroim.2006.08.004","volume":"181","author":"J Yin","year":"2006","unstructured":"Yin J, Albert RH, Tretiakova AP, Jameson BA (2006) 5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes. J Neuroimmunol 181:68\u201381","journal-title":"J Neuroimmunol"},{"key":"1242_CR95","first-page":"395","volume":"80","author":"MR Young","year":"1993","unstructured":"Young MR, Kut JL, Coogan MP, Wright MA, Young ME, Matthews J (1993) Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology 80:395\u2013400","journal-title":"Immunology"},{"key":"1242_CR96","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<333::AID-IJC5>3.0.CO;2-S","volume":"67","author":"MR Young","year":"1996","unstructured":"Young MR, Wright MA, Lozano Y, Matthews JP, Benefield J, Prechel MM (1996) Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int J Cancer 67:333\u2013338","journal-title":"Int J Cancer"},{"key":"1242_CR97","first-page":"1327","volume":"1","author":"AH Zea","year":"1995","unstructured":"Zea AH, Curti BD, Longo DL, Alvord WG, Strobl SL, Mizoguchi H, Creekmore SP, O\u2019Shea JJ, Powers GC, Urba WJ et al (1995) Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1:1327\u20131335","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-014-1242-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1242-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:52:06Z","timestamp":1746305526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-014-1242-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,17]]},"references-count":100,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1007\/s00702-014-1242-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,17]]},"assertion":[{"value":"16 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}